These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7711449)

  • 1. Rabies veterinary virus vaccine produced in BHK-21 cells grown on microcarriers in a bioreactor.
    Gallegos Gallegos RM; Espinosa Larios EL; Ramos Ramírez L; Kretschmer Schmid R; Aguilar Setién A
    Arch Med Res; 1995; 26(1):59-63. PubMed ID: 7711449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
    Kallel H; Rourou S; Majoul S; Loukil H
    Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economical production of rabies vaccine on cell cultures].
    Lalosević D; Lazarević-Ivanc L; Stankov S
    Med Pregl; 1997; 50(11-12):565-8. PubMed ID: 9471524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
    Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
    Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trial of YU BHK Rabivak vaccine against rabies in volunteers].
    Lalosević V; Lazarević-Ivanc L; Lalosević D
    Med Pregl; 2001; 54 Suppl 1():23-7. PubMed ID: 12078123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells.
    Kallel H; Jouini A; Majoul S; Rourou S
    J Biotechnol; 2002 May; 95(3):195-204. PubMed ID: 12007860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effect in mice of the live rabies vaccine produced using the Göttingen bioreactor].
    Roth F; Ullrich MW
    Berl Munch Tierarztl Wochenschr; 1995 Dec; 108(12):471-5. PubMed ID: 8651900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of various immunochemical, biochemical and biological methods for the analysis of rabies virus production in tissue cultures.
    Adamovicz P; Aguilon F; David A; Le Fur R; Mazert MC; Perrin P; Reculard P; Sureau P
    Dev Biol Stand; 1983; 55():191-7. PubMed ID: 6677532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and replication of rabies virus in C6 rat glioma cells (clone CCL-107).
    Bordignon J; Piza AT; Alvarez-Silva M; Caporale GM; Carrieri ML; Kotait I; Zanetti CR
    Biologicals; 2001 Jun; 29(2):67-73. PubMed ID: 11580211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production.
    Mondal SK; Neelima M; Seetha Rama Reddy K; Ananda Rao K; Srinivasan VA
    Biologicals; 2005 Sep; 33(3):185-9. PubMed ID: 16084736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of influenza virus in serum-free mammalian cell cultures.
    Merten OW; Manuguerra JC; Hannoun C; van der Werf S
    Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process.
    Pay TW; Boge A; Menard FJ; Radlett PJ
    Dev Biol Stand; 1985; 60():171-4. PubMed ID: 3899780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rabies vaccine produced in a non-tumorigenic rabbit cell line.
    Sureau P; Perrin P; Horaud F
    Dev Biol Stand; 1985; 60():133-9. PubMed ID: 4043531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simplified roller bottle platform for the production of a new generation VLPs rabies vaccine for veterinary applications.
    Fontana D; Marsili F; Garay E; Battagliotti J; Etcheverrigaray M; Kratje R; Prieto C
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():70-75. PubMed ID: 31300130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.
    Perrin P; Madhusudana S; Gontier-Jallet C; Petres S; Tordo N; Merten OW
    Vaccine; 1995 Sep; 13(13):1244-50. PubMed ID: 8578811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.